A recent review examined to what extent childhood obesity increases the risk of various autoimmune diseases in adulthood, including type 1 diabetes (T1D), and the benefits that accrue if weight reduction begins in early life.
Childhood obesity increases the risk for autoimmune diseases, such as type 1 diabetes (T1D), later in life, according to a recent review.
The researchers, writing in the Journal of Internal Medicine, said the risk can be modified by weight reduction, but that the effect appears to be dependent on the age at which weight loss occurs, as well as the specific disease.
According to the World Health Organization, childhood obesity is one of the most serious challenges of the 21st century, with more than 100 million children having obesity.
During childhood, almost all organs are at risk of being affected by obesity, which is implicated not only in T1D but also type 2 diabetes, multiple sclerosis, Crohn disease, arthritis, asthma, cardiovascular disease, and nonalcoholic fatty liver disease, among others.
Consequently, childhood obesity increases the risk for premature mortality.
According to the report, obesity affects the immune system directly and indirectly, with direct effects stemming from immunological changes in the adipose tissue, and indirect effects from endocrinological alterations.
When a child has obesity, chronic low-grade inflammation takes place as fat cells in adipose tissue enlarge, increasing cytokines, macrophages, and lymphocytes. In the context of T1D, it has been proposed that obesity induces insulin resistance. However, the linkl between obesity and T1D is complex and is influenced by genetic factors.
Obesity-induced inflammation may increase the risk of developing T1D with only 1 type of autoantibody present, and may further drive a shift from 1 to 2 autoantibodies in childhood and adolescence. However, this only occurs in specific genetic groups.
"The effects of early childhood obesity on immunological processes and the development of autoimmune diseases are relatively recently clarified and our understanding of mechanisms and how to prevent these diseases are still limited," the authors wrote.
The authors assert that, as the associations between obesity and disease are found before puberty, early treatment of obesity is required to reduce the incidence of immunological-related diseases.
While the risks associated with childhood obesity are modified by weight loss, the risk reduction is affected by the age that weight loss occurs. The report indicates that effect of weight loss on future disease risk seems is also disease dependent. In general, weight loss before puberty is more beneficial, but there are disease-specific differences.
The authors cautioned that as weight loss in children and adolescents is difficult, and treatments that were in effect decades ago were limited and often not effective, any links between weight loss and long-term comorbidities must be handled carefully and studied further.
Reference
Marcus C, Danielsson P, Hagman E. Pediatric obesity–long-term consequences and effect of weight loss. J Intern Med. Published online July 26, 2022. doi:10.1111/joim.13547
Study Shows Higher Infection Risk in Patients With T1D in Primary, Secondary Care
November 22nd 2023Researchers concluded there is a clinically important increase in infection risk among patients with T1D in both primary care and hospital settings, and that guidelines must be developed to reflect this risk and encourage earlier treatment.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
High BMI Associated With Increased Risk of Type 1 Diabetes
November 10th 2023In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes.
Read More
Glucose Fluctuation Linked to Slowed Nerve Conduction Velocity in Youth With T1D
November 2nd 2023High glucose variability in children and young adults with type 1 diabetes (T1D) strongly predicted slowed nerve conduction velocity, a forerunner of diabetic peripheral neuropathy, in a recent study.
Read More